Suppr超能文献

腹腔注射体积和抗体蛋白剂量对大鼠腹腔注射IgG2a κ小鼠单克隆抗体药代动力学的影响。

Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat.

作者信息

Barrett J S, Wagner J G, Fisher S J, Wahl R L

机构信息

Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109.

出版信息

Cancer Res. 1991 Jul 1;51(13):3434-44.

PMID:1905196
Abstract

The i.p. route of antibody administration offers a regional delivery advantage to the peritoneal cavity. In an effort to optimize this method of delivery, the volume of i.p. injection and total protein dose were examined for their effect on the absorption and disposition of an IgG2a kappa murine monoclonal antibody. 5G6.4, administered i.p. Normal rats (Sprague-Dawley) were given one of two protein doses (1-2 or 100 micrograms) of 125I-5G6.4 in a 2.0-ml i.p. injection volume. In both cases the same radiation dose (approximately 20 mu Ci/rat) was administered since only the tracer level (1-2 micrograms) was labeled. Hence, the 100-micrograms dose consisted of approximately 2 micrograms of labeled antibody with 98 micrograms of unlabeled antibody. In a separate experiment, two i.p. injection volumes (2.0 or 20.0 ml) of 125I-5G6.4 (approximately 20 mu Ci/rat) were administered to normal Sprague-Dawley rats. Pharmacokinetic modeling of the whole blood radioactivity levels was undertaken for both groups. The liver, kidney, muscle, lung, diaphragm, and anterior mediastinal lymph nodes were excised upon sacrifice and tissue levels at sacrifice were recorded. The volume of i.p. injection is shown to be a significant factor with respect to i.p. transport. Maximum concentration in the blood, Cmax, was reduced (P less than 0.1) and time of maximum concentration, tCmax was prolonged (P less than 0.05) from 8.4 h (in the 2-ml group) to 14.5 h (in the 20-ml group). Both contribute to a modest reduction in AUC(0----infinity) (P less than 0.15) in which AUC is the area under the concentration-time curve. The increase in blood clearance, Clb, at the higher injection volume (0.287 ml/h for the 20-ml volume and 0.194 ml/h for the 2-ml volume) is presumably due to increased diuresis resulting from autoregulation of fluid removal via lymphatic drainage. Volume of distribution, Vd, is increased since Vd and Clb are functionally proportionate and elimination is assumed constant. Tissue levels at sacrifice, except for the thyroid and anterior mediastinal lymph nodes, were the same. Mean thyroid levels were reduced in the 20-ml group (P less than 0.05) by 22.5%, likely as a result of increased diuresis. Increased nodal uptake (P less than 0.01) can be attributed to the dilution effect of the bolus injection. The rate of mass transfer is greater for the 2-ml group up to 4 h postinjection. Subsequently, the mass transfer rate is greater for the 20-ml group.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

腹腔注射抗体的途径为腹腔提供了区域给药优势。为了优化这种给药方法,研究了腹腔注射体积和总蛋白剂量对IgG2a κ小鼠单克隆抗体5G6.4吸收和处置的影响。5G6.4通过腹腔注射给予正常大鼠(斯普拉格-道利大鼠)。两种蛋白剂量(1 - 2或100微克)的125I - 5G6.4以2.0毫升的腹腔注射体积给予大鼠。在两种情况下,给予相同的辐射剂量(约20微居里/只大鼠),因为仅示踪剂水平(1 - 2微克)被标记。因此,100微克剂量由约2微克标记抗体和98微克未标记抗体组成。在另一个实验中,将两种腹腔注射体积(2.0或20.0毫升)的125I - 5G6.4(约20微居里/只大鼠)给予正常斯普拉格-道利大鼠。对两组全血放射性水平进行了药代动力学建模。处死时切除肝脏、肾脏、肌肉、肺、膈肌和前纵隔淋巴结,并记录处死时的组织水平。腹腔注射体积显示是影响腹腔转运的一个重要因素。血液中的最大浓度Cmax降低(P < 0.1),最大浓度出现时间tCmax延长(P < 0.05),从8.4小时(2毫升组)延长至14.5小时(20毫升组)。这两者都导致浓度-时间曲线下面积AUC(0→∞)适度降低(P < 0.15)。较高注射体积时血液清除率Clb增加(20毫升体积时为0.287毫升/小时,2毫升体积时为0.194毫升/小时),推测是由于通过淋巴引流自动调节液体清除导致利尿增加。分布容积Vd增加,因为Vd和Clb在功能上成比例,且假定消除是恒定的。处死时除甲状腺和前纵隔淋巴结外,组织水平相同。20毫升组的平均甲状腺水平降低(P < 0.05)22.5%,可能是利尿增加的结果。淋巴结摄取增加(P < 0.01)可归因于推注注射的稀释效应。注射后4小时内,2毫升组的质量转移速率更高。随后,20毫升组的质量转移速率更高。(摘要截断于400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验